Terazosin and Parkinson's Disease Extension Study

Clinical trial NCT05109364 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05109364
Sponsor: Cedars-Sinai Medical Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Symptomatic Parkinson Disease REM Sleep Behavior Disorder Pre-motor Parkinson's Disease

Start date: 2022-09-23
Primary completion: 2026-03-10
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.